Share
Market Research Report

CEFTAZIDIME AVIBACTAM MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By TypeCombination (CAZ/AVI) · Ceftazidime (CAZ) · and Avibactam (AVI)
  • By IndicationComplicated intra-abdominal infections · Complicated urinary tract infections · Hospital-acquired bacterial pneumonia · Ventilator-associated bacterial pneumonia · Bloodstream infections caused by carbapenem-resistant organisms · and Other multidrug-resistant Gram-negative infections
  • By Dosage FormInjectable · Powder for Reconstitution · and Pre-filled Syringes
  • By Drug TypeBranded and Generic
  • By End UserTertiary-care hospitals · Secondary-care hospitals · Long-term acute-care facilities · and Specialized infectious disease centers
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In01 Apr 2026
  • Report CodeCMI9055
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Combination (CAZ/AVI)
    • Ceftazidime (CAZ)
    • Avibactam (AVI)

  • Indication Insights (Revenue, USD Bn, 2021 - 2033)

    • Complicated intra-abdominal infections
    • Complicated urinary tract infections
    • Hospital-acquired bacterial pneumonia
    • Ventilator-associated bacterial pneumonia
    • Bloodstream infections caused by carbapenem-resistant organisms
    • Other multidrug-resistant Gram-negative infections

  • Dosage Form Insights (Revenue, USD Bn, 2021 - 2033)

    • Injectable
    • Powder for Reconstitution
    • Pre-filled Syringes

  • Drug Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Branded
    • Generic

  • End User Insights (Revenue, USD Bn, 2021 - 2033)

    • Tertiary-care hospitals
    • Secondary-care hospitals
    • Long-term acute-care facilities
    • Specialized infectious disease centers

  • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa